Midjourney, the AI image company, has opened a healthcare division built around a full-body scanner it claims produces a 3D view of your internal anatomy in under 60 seconds, against the 60 to 90 minutes a typical MRI takes.
The imaging itself is not Midjourney's invention. Each prototype runs on 40 of Butterfly Network's ultrasound-on-chip modules under a licence Butterfly disclosed in a November 2025 SEC filing, worth up to US$74 million over five years. When the scanner was unveiled, Butterfly's shares jumped about 31% to a four-year high, which tells you who the market thinks owns the hard part.
The hardware is real and proven, but the product is not. Midjourney still needs FDA clearance for any diagnostic use, and its first scanning "spa" in San Francisco is not slated to open until late 2027. For now it is a striking demo wrapped around someone else's silicon.